David McClung, Chief Financial Officer at BioCardia, Inc. (BCDA), bought 1,600 shares at $2.56 ($4K) on 2018-11-05, disclosed to the SEC on 2018-11-07.
Open-market purchase of $4k BCDA by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| BCDA | BUY | 2022-10-11 | $4K | — | Filing → |
| BCDA | BUY | 2018-10-16 | $1K | — | Filing → |
| BCDA | BUY | 2018-09-25 | $7K | — | Filing → |